Overview

Study of Safety of Foradil in Patients With Persistent Asthma

Status:
Terminated
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess whether the risk of serious asthma-related events (asthma-related hospitalizations, asthma related intubations, and asthma related deaths) in adolescents and adults (12 years of age and older) taking inhaled formoterol fumarate/fluticasone propionate combination was the same as those taking inhaled fluticasone propionate alone.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Fluticasone
Formoterol Fumarate
Xhance